Expected earnings - Galmed Pharmaceuticals Ltd.
Source: US Earnings Reports
Galmed Pharmaceuticals Ltd. (GLMD) is expected to report for quarter end 2025-06-30
Galmed Pharmaceuticals Ltd.
NASDAQ: GLMD
GLMD Trading
-0.78% G/L:
$0.635 Last:
3,274 Volume:
$0.669 Open:
GLMD Latest News
January 30, 2026 04:15:00 pm
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
December 08, 2025 08:30:00 am
Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting
GLMD Stock Data
$3,725,877
5,281,979
N/A
25
N/A
Biotechnology & Life Sciences
Healthcare
IL
Ramat Gan
